Satu Mustjoki gives a Frontiers of science eTALK on hematological malignancies

Mustjoki portrait with BioCity Turku logo

BioCity Turku invites Professor Satu Mustjoki from University of Helsinki to give a Frontiers of Science eTALK “Immune landscape of hematological malignancies and immunomonitoring at a single cell level” on November 26th at 12:00


The second last FoS talk of this autumn season is given by Satu Mustjoki, MD, PhD, a professor of Translational Hematology at the University of Helsinki and a specialist in Clinical Chemistry (laboratory hematology). Mustjoki has led several translational immunological biomarker studies in conjunction with the international clinical trials in leukemia. Her current research focuses on tumor immunology and on the molecular mechanisms of T-cell malignancies and associated autoimmune disorders and is supported by ERC among several other national and international awards ( Mustjoki leads the Translational Immunology Research Program at the Faculty of Medicine, University of Helsinki, Finland ( and she has more than 140 publications including those published in New England Journal of Medicine, Nature Genetics, Nature Communications, Blood, and Cancer Cell.


November 26th at 12:00
Virtual event

Prof. Satu Mustjoki, University of Helsinki, Finland
Immune landscape of hematological malignancies and immunomonitoring at a single cell level
host: Riitta Lahesmaa (
pdf flier

Registration is open until November 24th

Students and early-career are welcome to join a virtual cup of coffee and discuss science with Prof. Mustjoki after the seminar.
This is a great possibility to learn hosting skills in friendly environment and create connections for future. Every student are welcome to join, in spite of which research group they belong to.
If you got interested, after registering to the event please send an email to